Your browser doesn't support javascript.
loading
Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
Okura, Yasushi; Namisaki, Tadashi; Moriya, Kei; Kitade, Mitsuteru; Takeda, Kosuke; Kaji, Kosuke; Noguchi, Ryuichi; Nishimura, Norihisa; Seki, Kenichiro; Kawaratani, Hideto; Takaya, Hiroaki; Sato, Shinya; Sawada, Yasuhiko; Shimozato, Naotaka; Furukawa, Masanori; Nakanishi, Keisuke; Saikawa, Soichiro; Kubo, Takuya; Asada, Kiyoshi; Yoshiji, Hitoshi.
Afiliação
  • Okura Y; Department of Endoscopy and Ultrasound, Nara Medical University, Kashihara, Nara, Japan.
  • Namisaki T; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Moriya K; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Kitade M; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Takeda K; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Kaji K; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Noguchi R; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Nishimura N; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Seki K; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Kawaratani H; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Takaya H; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Sato S; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Sawada Y; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Shimozato N; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Furukawa M; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Nakanishi K; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Saikawa S; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Kubo T; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Asada K; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Yoshiji H; Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan.
Hepatol Res ; 47(12): 1317-1328, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28029729
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão